Baylon, Erwin B.

HRN: 09-69-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/12/2026
01/18/2026
IVTT
2.25
Q6
Cap HR (renal Dose, Egfr: 38ml/min)
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines